is wegovy tirzepatide Zepbound Beats for Weight Loss in First Head-to-Head Trial Semaglutide vs Tirzepatide: Which GLP-1

[3] Synaptogenesis through HGF/c-Met

New JAMA Study Links Wegovy to NAION A JAMA study published on July 3, 2024, on the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide found an increased risk of the condition in patients taking semaglutide compared to those taking non-GLP-1 RA medications

Are You an Ideal Candidate for Semaglutide Treatment

The body appears to adapt to both the delayed gastric emptying effects and the central nervous system appetite-suppressing signals, resulting in reduced nausea, vomiting, and other GI symptoms even as doses increase to therapeutic levels

Before and after using needles: how our patients views changed Much of the conversation around GLP-1 treatments focuses on the fear of needles before treatment begins